SEC Form 4 · accession 0001415889-16-004391
ACADIA PHARMACEUTICALS INC · ACAD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James M Daly
Director
Period of report
Jan 7, 2016
Accepted (ET)
Jan 11, 2016 · 7:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070494
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $28.73 | Jan 7, 2016 | A | 15,000 | A | — | Jan 6, 2026 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F150% of the shares subject to the Stock Option vest and become exercisable on each of the first and second anniversary of the date of grant.